Evidence map›Paper›PMID 26220362›Full record

ArticleStem cells (Dayton, Ohio)2015

Wnt/β-Catenin-Responsive Cells in Prostatic Development and Regeneration.

Suk Hyung Lee, Daniel T Johnson, Richard Luong, Eun Jeong Yu, Gerald R Cunha, Roel Nusse, Zijie Sun

Open access · bronzeAbstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 30 citations in OpenAlex.

  1. Stem-cell regulation in periodontium formation and regeneration.Journal of bone and mineral metabolism · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Androgens trigger different growth responses in genetically identical human hair follicles in organ culture that reflect their epigenetic diversity in life.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Suk Hyung LeeDepartment of Urology, Stanford University School of Medicine, Stanford, California, USA.
Daniel T JohnsonDepartment of Urology, Stanford University School of Medicine, Stanford, California, USA.
Richard LuongDepartment of Comparative Medicine, Stanford University School of Medicine, Stanford, California, USA.
Eun Jeong YuDepartment of Urology, Stanford University School of Medicine, Stanford, California, USA.
Gerald R CunhaDepartment of Urology, School of Medicine, University of California San Francisco, San Francisco, California, USA.
Roel NusseDepartment of Developmental Biology and Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, California, USA.
Zijie SunDepartment of Urology, Stanford University School of Medicine, Stanford, California, USA.
Stanford University · USHoward Hughes Medical Institute · USUniversity of California, San Francisco · US

Funding

Roles of the androgen receptor and its co-regulators in prostate tumorigenesisR01CA070297 · NCI · STANFORD UNIVERSITY · PI SUN, ZIJIE · 2003 to 2025
$5.0M
Wnt responsive stem cells in the prostateR01DK104941 · NIDDK · STANFORD UNIVERSITY · PI SUN, ZIJIE · 2015 to 2024
$3.0M
A new regulator for Wnt/beta-catenin signaling and prostate tumorigenesisR01CA151623 · NCI · STANFORD UNIVERSITY · PI SUN, ZIJIE · 2011 to 2015
$1.7M
A New Mechanism for Castration Resistant Prostate CancerR01CA166894 · NCI · STANFORD UNIVERSITY · PI SUN, ZIJIE · 2015 to 2018
$1.2M
A New Mechanism for Castration Resistant Prostate CancerU01CA166894 · NCI · STANFORD UNIVERSITY · PI SUN, ZIJIE · 2013 to 2014
$729k
Cellular And Molecular Properties Of PINs In Prostate TumorigenesisR21CA190021 · NCI · STANFORD UNIVERSITY · PI SUN, ZIJIE · 2014 to 2016
$401k
NCI NIH HHS R01 CA070297NCI NIH HHS R01CA070297NCI NIH HHS R01 CA151623NCI NIH HHS R01CA151623NCI NIH HHS R01 CA166894NCI NIH HHS R21 CA190021NCI NIH HHS R21CA190021NCI NIH HHS U01 CA166894NCI NIH HHS U01CA166894NIDDK NIH HHS R01 DK104941NIDDK NIH HHS R01DK104941
6 · The paper itself

Abstract

The precise role of Wnt/β-catenin signaling during prostatic development and tumorigenesis is unclear. Axin2 is a direct transcriptional target of β-catenin. Recent studies have shown that Axin2-expressing cells have stem/progenitor cell properties in a variety of mouse tissues. Here, we genetically labeled Axin2-expressing cells at various time points and tracked their cellular behavior at different developmental and mature stages. We found that prostatic Axin2-expressing cells mainly express luminal epithelial cell markers and are able to expand luminal cell lineages during prostatic development and maturation. They can also survive androgen withdrawal and regenerate prostatic luminal epithelial cells following androgen replacement. Deletion of β-catenin or expression of stabilized β-catenin in these Axin2-expressing cells results in abnormal development or oncogenic transformation, respectively. Our study uncovers a critical role of Wnt/β-catenin-responsive cells in prostatic development and regeneration, and that dysregulation of Wnt/β-catenin signaling in these cells contributes to prostatic developmental defects and tumorigenesis.

Indexed as

AnimalsAxin Proteinbeta CateninCell LineageEpithelial CellsMaleMiceMice, TransgenicOrganogenesisProstateRegenerationWnt Signaling PathwayAxin2 protein, mouseAxin Proteinbeta CateninAxin2Prostatic progenitor cellsWnt signalingβ-Catenin

Identifiers

PMID26220362
PMCPMC4618081
OpenAlexW2101765323

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.